APA-Zitierstil (7. Ausg.)

Grimm, M., Schmitz-Dräger, B. J., Zimmermann, U., Grün, B., Baretton, G. B., Schmitz, M., . . . Meran, J. (2022). Tailored immunotherapy approach with Nivolumab in advanced transitional cell carcinoma. Journal of clinical oncology, 40(19), . https://doi.org/10.1200/JCO.21.02631

Chicago-Zitierstil (17. Ausg.)

Grimm, Marc-Oliver, et al. "Tailored Immunotherapy Approach with Nivolumab in Advanced Transitional Cell Carcinoma." Journal of Clinical Oncology 40, no. 19 (2022). https://doi.org/10.1200/JCO.21.02631.

MLA-Zitierstil (9. Ausg.)

Grimm, Marc-Oliver, et al. "Tailored Immunotherapy Approach with Nivolumab in Advanced Transitional Cell Carcinoma." Journal of Clinical Oncology, vol. 40, no. 19, 2022, https://doi.org/10.1200/JCO.21.02631.